Amphastar Pharmaceuticals logo

Amphastar Pharmaceuticals

AMPH | NASDAQ
Chart Builder DCF Calculator
$29.17
-$0.20 (-0.68%)
At close: Nov 16, 2026, 4:00 PM ET
$29.17
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-0.68%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
64.1
Fundamentals Strong
Market Sentiment Bullish
Moat Narrow
Sector Rank #102/1021 (Top 10%)

Key Statistics

Market Data

Market Cap $1.24B
1D Range
29.11 30.10
52W Range
16.87 30.10

Valuation (TTM)

PE 13.32
PB 1.53
EV/EBITDA 7.73

Valuation (NTM)

Forward PE 9.18
Forward PEG -1.87
Price Target $23.00
Loading financial charts...

Profile

Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commerc...

Sector Healthcare
Employees 1,976
IPO Date Jun 25, 2014
Fiscal Year January - December

Latest News

Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2026 Earnings Call Transcript

10 days ago · seekingalpha.com

Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2026 Earnings Call Transcript
Amphastar (AMPH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

11 days ago · zacks.com

Amphastar (AMPH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Amphastar Pharmaceuticals Q3 Earnings Call Highlights

11 days ago · marketbeat.com

Amphastar Pharmaceuticals Q3 Earnings Call Highlights
Amphastar Pharmaceuticals (AMPH) Tops Q3 Earnings and Revenue Estimates

11 days ago · zacks.com

Amphastar Pharmaceuticals (AMPH) Tops Q3 Earnings and Revenue Estimates
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026

11 days ago · prnewswire.com

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for

19 days ago · zacks.com

Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 5, 2026

19 days ago · prnewswire.com

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 5, 2026
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?

1 month ago · zacks.com

Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2026 Earnings Call Transcript

6 months ago · seekingalpha.com

Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2026 Earnings Call Transcript
Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics

6 months ago · zacks.com

Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics

Earnings

Latest Earnings
Nov 5, 2026
EPS
$1.14
Beat +32.71%
REV
$207.61M
Beat +5.11%
Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
6
Consensus
Hold
Price Target
$23.00
Downside
-21.15%
Buy (0)
Hold (5)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.